These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 26571446)

  • 21. Usefulness of partial volume effect-corrected F-18 FDG PET/CT for predicting I-131 accumulation in the metastatic lymph nodes of patients with thyroid carcinoma.
    Maruoka Y; Abe K; Baba S; Isoda T; Kitamura Y; Mizoguchi N; Akamatsu G; Sasaki M; Honda H
    Ann Nucl Med; 2013 Dec; 27(10):873-9. PubMed ID: 24002992
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ultrasonographic Features of the Major Salivary Glands after Radioactive Iodine Ablation in Patients with Papillary Thyroid Carcinoma.
    Kim DW
    Ultrasound Med Biol; 2015 Oct; 41(10):2640-5. PubMed ID: 26215493
    [TBL] [Abstract][Full Text] [Related]  

  • 23. I-131 remnant ablation after thyroidectomy induced hepatotoxicity in a case of thyroid cancer.
    Lin R; Banafea O; Ye J
    BMC Gastroenterol; 2015 May; 15():56. PubMed ID: 25947546
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The rationale of patients with early-stage papillary thyroid cancer for accepting or rejecting radioactive iodine remnant ablation.
    Sawka AM; Rilkoff H; Tsang RW; Brierley JD; Rotstein L; Ezzat S; Asa SL; Segal P; Kelly C; Zahedi A; Gafni A; Goldstein DP
    Thyroid; 2013 Feb; 23(2):246-7. PubMed ID: 23009127
    [No Abstract]   [Full Text] [Related]  

  • 25. False-positive uptake of I-131 in a laryngocele mimicking thyroid remnant after thyroidectomy for papillary thyroid carcinoma.
    Schmidt M; Dietlein M; Schröder U; Schicha H
    Clin Nucl Med; 2006 Nov; 31(11):716-7. PubMed ID: 17053394
    [TBL] [Abstract][Full Text] [Related]  

  • 26. False-positive uptake of 124I in a laryngeal cyst mimicking thyroid remnant after thyroidectomy and 131i therapy for follicular thyroid carcinoma.
    Noordman BJ; Comans E; Lips P; Rinkel RN
    Clin Nucl Med; 2014 Oct; 39(10):898-9. PubMed ID: 24561682
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Esophageal metastasis from papillary thyroid cancer: diagnosis by 131I SPECT/CT.
    Wisotzki C; Friese M; Ehresmann J; Derlin T
    Clin Nucl Med; 2014 Jan; 39(1):e73-4. PubMed ID: 23455522
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of iodinated contrast agent administered during preoperative computed tomography scan on body iodine pool in patients with differentiated thyroid cancer preparing for radioactive iodine treatment.
    Sohn SY; Choi JH; Kim NK; Joung JY; Cho YY; Park SM; Kim TH; Jin SM; Bae JC; Lee SY; Chung JH; Kim SW
    Thyroid; 2014 May; 24(5):872-7. PubMed ID: 24295076
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Occult papillary thyroid carcinoma in thyroglossal cyst diagnosed by (18)FDG PET/CT scan].
    Serrano Vicente J; Infante Torre JR; Rayo Madrid JI; García Bernardo L; Domínguez Grande ML; Durán Barquero C; Sánchez Sánchez R
    Rev Esp Med Nucl Imagen Mol; 2012; 31(4):229-30. PubMed ID: 22980131
    [No Abstract]   [Full Text] [Related]  

  • 30. Thyroid ablation with 1.1 GBq (30 mCi) iodine-131 in patients with papillary thyroid carcinoma at intermediate risk for recurrence.
    Rosário PW; Calsolari MR
    Thyroid; 2014 May; 24(5):826-31. PubMed ID: 24283207
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Thymic uptake of 18FFDG following radioiodine ablation therapy].
    Albalá González MD; Martínez Gimeno E; Cárdenas Negro C; Allende Riera A; Cabello García D; De Sequera Rahola M; Uña Gorospe JA
    Rev Esp Med Nucl; 2011; 30(5):314-6. PubMed ID: 21342725
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intramedullary spinal cord metastasis from papillary thyroid carcinoma.
    Jeon MJ; Kim TY; Han JM; Yim JH; Rhim SC; Kim WB; Shong YK
    Thyroid; 2011 Nov; 21(11):1269-71. PubMed ID: 21936676
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decision aid on radioactive iodine treatment for early stage papillary thyroid cancer: update to study protocol with follow-up extension.
    Sawka AM; Straus S; Rodin G; Thorpe KE; Ezzat S; Gafni A; Goldstein DP
    Trials; 2015 Jul; 16():302. PubMed ID: 26169592
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does recombinant human thyrotropin-stimulated positron emission tomography with [18F]fluoro-2-deoxy-D-glucose improve detection of recurrence of well-differentiated thyroid carcinoma in patients with low serum thyroglobulin?
    Vera P; Kuhn-Lansoy C; Edet-Sanson A; Hapdey S; Modzelewski R; Hitzel A; d'Anjou J; Basuyau JP
    Thyroid; 2010 Jan; 20(1):15-23. PubMed ID: 20017617
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased 131I accumulation in the polyacrylamide hydrophilic gel used for breast augmentation.
    Lv J; Qu Y; Zhang M; Pan Y; Zhang Y
    Clin Nucl Med; 2014 Apr; 39(4):415-6. PubMed ID: 24566417
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Iodine-131 SPET/CT and 18F-FDG PET/CT for the identification and localization of mediastinal lymph node metastases from differentiated thyroid carcinoma.
    Xu YH; Shen CT; Xue YL; Qiu ZL; Luo QY
    Hell J Nucl Med; 2013; 16(3):199-203. PubMed ID: 24251307
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bilateral renal metastases from papillary thyroid carcinoma on post 131I treatment scan: flip-flop sign, radioiodine SPET, 18F-FDG PET, CECT and histopathological correlation.
    Borde C; Basu S; Kand P; Arya S; Shet T
    Hell J Nucl Med; 2011; 14(1):72-3. PubMed ID: 21512673
    [No Abstract]   [Full Text] [Related]  

  • 38. Papillary carcinoma simultaneously involving thyroid, neck lymph-nodes, ovary and bone marrow.
    Giovanella L; Suriano S; Ceriani L; Verburg FA
    Nuklearmedizin; 2010; 49(6):N66-8. PubMed ID: 21140033
    [No Abstract]   [Full Text] [Related]  

  • 39. Fluorodeoxyglucose PET/CT in patients with differentiated thyroid cancer and elevated thyroglobulin after total thyroidectomy and (131)I ablation.
    Salvatore B; Paone G; Klain M; Storto G; Nicolai E; D'Amico D; Della Morte AM; Pace L; Salvatore M
    Q J Nucl Med Mol Imaging; 2008 Mar; 52(1):2-8. PubMed ID: 17538522
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined [18F]Fluorodeoxyglucose positron emission tomography and computed tomography (FDG-PET/CT) for detection of recurrent, 131I-negative thyroid cancer.
    Finkelstein SE; Grigsby PW; Siegel BA; Dehdashti F; Moley JF; Hall BL
    Ann Surg Oncol; 2008 Jan; 15(1):286-92. PubMed ID: 17882493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.